fenistil 1 mg/ml peroralne kapljice, raztopina
glaxosmithkline dungarvan ltd - dimetindenijev maleat - peroralne kapljice, raztopina - dimetindenijev maleat 1 mg / 1 ml - dimetinden
aripiprazol accord healthcare 10 mg tablete
actavis group ptc ehf. - aripiprazol - tableta - aripiprazol 10 mg / 1 tableta - aripiprazol
fluorouracil accord 50 mg/ml raztopina za injiciranje/infundiranje
accord healthcare - fluorouracil - raztopina za injiciranje/infundiranje - fluorouracil 50 mg / 1 ml - fluorouracil
fluorouracil accord 50 mg/ml raztopina za injiciranje/infundiranje
accord healthcare - fluorouracil - raztopina za injiciranje/infundiranje - fluorouracil 50 mg / 1 ml - fluorouracil
panadol koflen 500 mg/65 mg filmsko obložene tablete
glaxosmithkline consumer healthcare (uk) trading limited - kofein; paracetamol - filmsko obložena tableta - kofein 65 mg / 1 tableta paracetamol500 mg / 1 tableta; paracetamol 500 mg / 1 tableta - paracetamol, kombinacije brez psiholeptikov
capecitabine accord
accord healthcare s.l.u. - kapecitabin - colonic neoplasms; breast neoplasms; colorectal neoplasms; stomach neoplasms - antineoplastična sredstva - capecitabine accord je indiciran za adjuvantno zdravljenje bolnikov po operaciji stopnje iii (dukes 'stadij c) raka debelega črevesa. capecitabine soglasju je primerna za zdravljenje metastatskega raka debelega črevesa in danke. capecitabine soglasju je določen za prvo linijo zdravljenja naprednih raka želodca v kombinaciji z platinum, ki temelji režim. capecitabine sebe v kombinaciji z docetaxel je indiciran za zdravljenje bolnikov z lokalno napredno ali metastatskega raka dojke po okvari citotoksična kemoterapija. predhodno zdravljenje bi moralo vključiti antraciklin. capecitabine soglasju navede tudi kot monotherapy za zdravljenje bolnikov z lokalno napredno ali metastatskega raka dojke po okvari taxanes in anthracycline, ki vsebujejo kemoterapijo režim ali za koga še anthracycline zdravljenje ni navedeno.
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastična sredstva - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastična sredstva - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
fluorouracil accord 50 mg/ml raztopina za injiciranje/infundiranje
accord healthcare - fluorouracil - raztopina za injiciranje/infundiranje - fluorouracil 50 mg / 1 ml - fluorouracil
dolocarp flavour tablete
animedica gmbh stran od 5 im südfeld 9 48308 senden -